thienopyridine
Showing 1 - 25 of 123
Complication of Coronary Artery Bypass Graft, Peri-operative Hemorrhage or Hematoma, Post Operative Bleeding Trial (Platelet
Completed
- Complication of Coronary Artery Bypass Graft
- +2 more
- Platelet reactivity assessment
- (no location specified)
Mar 11, 2021
Peptic Ulcer Trial in Kaohsiung (histamine-2 receptor antagonist group, proton pump inhibitor group)
Completed
- Peptic Ulcer
- histamine-2 receptor antagonist group
- proton pump inhibitor group
-
Kaohsiung, TaiwanKaohsiung Veterans General Hospital
Jun 24, 2019
Peptic Ulcer Trial in Kaohsiung (histamine-2 receptor antagonist, Placebo)
Completed
- Peptic Ulcer
- histamine-2 receptor antagonist
- Placebo
-
Kaohsiung, TaiwanKaohsiung Veterans General Hospital
Mar 8, 2019
Upper Gastrointestinal Bleeding, Peptic Ulcer Hemorrhage, Anticoagulant-induced Bleeding Trial in Ann Arbor (Clinician
Completed
- Upper Gastrointestinal Bleeding
- +2 more
- Clinician Notification with Nurse Facilitation (CNNF)
- Wait list control
-
Ann Arbor, MichiganUniversity of Michigan
Jan 4, 2023
Coronary Artery Disease, Coronary Thrombosis Trial in La Jolla (Medtronic Endeavor Stent, Reduced duration (6 months) DAPT)
Completed
- Coronary Artery Disease
- Coronary Thrombosis
- Medtronic Endeavor Stent
- Reduced duration (6 months) DAPT
-
La Jolla, CaliforniaScripps Clinic
Oct 19, 2020
Ischemic Stroke Trial in Kafr Ash Shaykh (Ticagrelor 90 MG, Clopidogrel)
Recruiting
- Ischemic Stroke
- Ticagrelor 90 MG
- Clopidogrel
-
Kafr Ash Shaykh, EgyptKafr Elsheikh University Hospital
Nov 7, 2023
Ischemic Stroke Trial in Kafr Ash Shaykh (Ticagrelor 90 MG Oral Tablet, Clopidogrel tablet)
Recruiting
- Ischemic Stroke
- Ticagrelor 90 MG Oral Tablet
- Clopidogrel tablet
-
Kafr Ash Shaykh, EgyptKafr Elsheikh University Hospital
Nov 18, 2022
Coronary Artery Disease Trial in Japan, United States (PROMUS Element Everolimus-Eluting Coronary Stent System, Aspirin,
Completed
- Coronary Artery Disease
- PROMUS Element Everolimus-Eluting Coronary Stent System
- +2 more
-
Loveland, Colorado
- +4 more
Mar 13, 2019
Cancer Associated Thrombosis : What is Proportion of Patients
Recruiting
- Venous Thromboembolism
- Cancer
- data collection
-
Amiens, France
- +2 more
Apr 16, 2021
Coronary Artery Disease Trial in Seoul (Dual antiplatelet therapy with a P2Y12 inhibitor plus aspirin)
Recruiting
- Coronary Artery Disease
- Dual antiplatelet therapy with a P2Y12 inhibitor plus aspirin
-
Seoul, Korea, Republic of
- +1 more
Nov 10, 2021
Aggregometry in Elderlies With Hip Fracture and Receiving
Unknown status
- Hip Fractures
- +2 more
- Aggregometry
-
Catanzaro, ItalyFederico Longhini
Nov 23, 2020
Acute Coronary Syndrome, Lipid Disorder, Coronary Artery Disease Trial in Dallas (Polypill, Control treatment)
Not yet recruiting
- Acute Coronary Syndrome
- +2 more
- Polypill
- Control treatment
-
Dallas, TexasUT Southwestern Medical Center
Aug 22, 2022
Cardiovascular Diseases, Adherence, Medication, Medication Adherence Trial in Aurora, Denver (Nudge)
Recruiting
- Cardiovascular Diseases
- +7 more
- Nudge
-
Aurora, Colorado
- +3 more
Jan 6, 2022
Multiple Electrode Aggregometry & Clopidogrel Resistance
Completed
- Type 2 Diabetes Mellitus (T2DM)
- +2 more
-
Athens, Haidari, Athens, Greece
- +2 more
Apr 8, 2021
Pharmacodynamics Trial in Busan (Ticagrelor 90 mg, Clopidogrel 600 mg)
Completed
- Pharmacodynamics
- Ticagrelor 90 mg
- Clopidogrel 600 mg
-
Busan, Korea, Republic ofDong A University Hospital
Jan 28, 2020
Plasma Transfusion in Major Vascular Surgery
Completed
- Aortic Aneurysm, Abdominal
- Arterial Occlusive Diseases
- Plasma transfusion
-
Slagelse, Region Zealand, DenmarkSlagelse Hospital
Jan 25, 2021
Coronary Artery Disease Trial in Worldwide (PROMUS Element Coronary Stent System, Aspirin, Thienopyridine)
Completed
- Coronary Artery Disease
- PROMUS Element Coronary Stent System
- +2 more
-
La Jolla, California
- +29 more
Mar 13, 2019
Antiplatelet Therapy, CYP2C19 Polymorphism Trial in Beijing (CYP2C19)
Recruiting
- Antiplatelet Therapy
- CYP2C19 Polymorphism
- CYP2C19
-
Beijing, Beijing, ChinaBeijing Anzhen Hospital
Dec 4, 2020
Ischemic Preconditioning Trial in Dallas (Coronary occlusion with balloon inflation)
Terminated
- Ischemic Preconditioning
- Coronary occlusion with balloon inflation
-
Dallas, Texas
- +1 more
Nov 23, 2020
Coronary Artery Disease Trial in United States (Prasugrel, Clopidogrel)
Completed
- Coronary Artery Disease
-
La Jolla, California
- +3 more
Jun 25, 2021
Drug-Eluting Stents, Percutaneous Coronary Intervention Trial in Shanghai (3 months DAPT, 12 months DAPT)
Unknown status
- Drug-Eluting Stents
- Percutaneous Coronary Intervention
- 3 months DAPT
- 12 months DAPT
-
Shanghai, ChinaShanghai Zhongshan Hospital
Sep 8, 2020
Aortic Valve Stenosis Trial in Athens (Ticagrelor plus ASA, Clopidogrel plus ASA)
Completed
- Aortic Valve Stenosis
- Ticagrelor plus ASA
- Clopidogrel plus ASA
-
Athens, Greece1st Department of Cardiology, Hippokration Hospital
Mar 1, 2021
Aspirin and Thienopyridine Resistance in Peripheral Arterial
Completed
- Peripheral Arterial Disease
- Clopidogrel, Poor Metabolism of
-
Sacramento, CaliforniaUC Davis Medical Center
May 31, 2017
Acute Coronary Syndrome Trial in Sheffield (Aspirin)
Completed
- Acute Coronary Syndrome
-
Sheffield, South Yorkshire, United KingdomSheffield Teaching Hospitals NHS Foundation Trust
Mar 16, 2021